Simplified Chinese

English

Home page

Deepening Government–Enterprise Communication to Boost Industrial Development — Ai Li, Secretary of the Party Group and Director of the Standing Committee of the Daxing District People’s Congress, Led a Research Visit to Minhai Biotechnology.

Release date:

2026-03-13

Author:

Source:

Abstract

On the morning of March 12, 2026, Ai Li, Party Secretary and Director of the Standing Committee of the District People’s Congress, led a delegation to the Daxing Biomedical Base. The group conducted an on-site visit and research at Beijing Minhai Biotechnology Co., Ltd. (hereinafter referred to as Minhai Bio), listened to the company’s development needs, and provided support for its high-quality growth. Accompanying the delegation were Gao Dongmei, Member of the Party Leadership Group and Director of the Office of the District People’s Congress Standing Committee; Li Hong, Party Secretary and Director of the District Finance Bureau; and Sun Luofu, Party Secretary and Director of the District Industrial Promotion Center. Upon arriving at Minhai Bio, the delegation inspected the company’s production and R&D operations and gained a detailed understanding of its latest achievements in vaccine development, manufacturing processes, international cooperation, and other areas.

2026 year 3 month 12 On the morning of [date], Ai Li, Party Secretary and Director of the Standing Committee of the District People’s Congress, led a delegation to the Daxing Biopharmaceutical Base. The group conducted an on-site visit and research at Beijing Minhai Biotechnology Co., Ltd. (hereinafter referred to as Minhai Bio), listened to the company’s development needs, and provided support for its high-quality growth. Accompanying the delegation were Gao Dongmei, Member of the Party Leadership Group and Director of the Office of the District People’s Congress Standing Committee; Li Hong, Party Secretary and Director of the District Finance Bureau; and Sun Luofu, Party Secretary and Director of the District Industrial Promotion Center.

The research delegation arrived at Minhai Biotechnology, where they conducted an on-site inspection of the company’s production and R&D operations and gained a detailed understanding of its latest achievements and progress in vaccine development, manufacturing processes, and international collaboration. Zheng Haifa, General Manager of Minhai Biotechnology, Liu Jiankai, Executive Deputy General Manager, and other company executives accompanied the delegation, providing briefings and engaging in in-depth discussions with the group on the company’s current status, future strategic plans, and the challenges it faces in its ongoing development.

Director Ai Li fully commended Minhai Bio’s achievements in the biopharmaceutical sector, encouraging the company to remain committed to an innovation-driven development philosophy, continue ramping up R&D investment, and steadily enhance its core technologies and market competitiveness, thereby injecting stronger momentum into the high-quality development of the biopharmaceutical industry. She emphasized that all relevant departments in the district will keep refining the business environment, strengthening policy coordination and delivering targeted services, doing their utmost to help enterprises overcome difficulties and providing robust support to enable them to grow stronger and more competitive.

This fact-finding mission has further streamlined communication channels between government and enterprises, bolstering business confidence. Moving forward, Minhai Bio will take this opportunity to focus on technological innovation and capacity expansion, continuously strengthening its foundations for growth and making new and greater contributions to the high-quality development of the biopharmaceutical industry in Daxing District.

Keywords:

The 2026 Kangtai Biological Supplier Conference was successfully held, with the company joining forces with its partners to chart a new course for high-quality development.

The company’s internal publication, “Minhai People”

Recommended Reading

Batch Release Status of the Company’s Products in 2026

The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.

Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.

Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09

Online Customer Service

Telephone

400 189 9806

Contact Information

Customer Service Hotline

4001899806

Phone number

010-59613600

Official Website

http://www.biominhai.com

Company Address

No. 35 Simiao Road and No. 25 Tianfu Street, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing

WeChat Official Account

Business license

Website Development: China Enterprise Dynamics

Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.